Obesity induces endothelial dysfunction through adipocyte dysfunction, oxidative stress, insulin resistance, and inflammation, serving as a key therapeutic target for cardiovascular events.
Obesity is a major public health problem and is related to increasing rates of cardiovascular morbidity and mortality. Over 1.9 billion adults are overweight or obese worldwide and the prevalence of obesity is increasing. Obesity influences endothelial function through obesity-related complications such as hypertension, dyslipidemia, diabetes, metabolic syndrome, and obstructive sleep apnea syndrome. The excess fat accumulation in obesity causes adipocyte dysfunction and induces oxidative stress, insulin resistance, and inflammation leading to endothelial dysfunction. Several anthropometric indices and imaging modalities that are used to evaluate obesity have demonstrated an association between obesity and endothelial function. In the past few decades, there has been great focus on the mechanisms underlying endothelial dysfunction caused by obesity for the prevention and treatment of cardiovascular events. This review focuses on pathophysiological mechanisms of obesity-induced endothelial dysfunction and therapeutic targets of obesity.
Kajikawa et al. (Tue,) conducted a review in Obesity. Obesity was evaluated. Obesity induces endothelial dysfunction through adipocyte dysfunction, oxidative stress, insulin resistance, and inflammation, serving as a key therapeutic target for cardiovascular events.